Current Report Filing (8-k)
May 17 2017 - 9:23AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported):
May 15, 2017
MEDICAL
TRANSCRIPTION BILLING, CORP.
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
333-192989
|
|
22-3832302
|
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
7
Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
As
previously reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, the Company
owes five million dollars to Prudential for the balance of the MediGain acquisition purchase price. As previously
disclosed, the remaining two million dollars of the purchase price was due on May 15, 2017 and is presently outstanding. On
March 29, 2017, the Company received a letter from Prudential that demanded immediate payment of the three million dollar
portion of the consideration and the Company anticipates receiving a similar notification regarding the two million dollar
portion of the balance that is due. The Company is currently attempting to arrive at a mutually agreeable resolution to
this matter.
SIGNATURE(S)
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
|
Medical
Transcription Billing, Corp.
|
|
|
|
|
Date:
May 17, 2017
|
By:
|
/s/
Mahmud Haq
|
|
|
|
Mahmud
Haq
Chairman
of the Board and Chief Executive Officer
|
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Nov 2024 to Dec 2024
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Dec 2023 to Dec 2024
